EAU 2008 - Advances in Targeted Therapy and Tissue Engineering in Urology: Targeted Therapy
Tuesday, 01 April 2008
MILAN, ITALY (UroToday.com) - When a patient comes to the pharmacist in the future he may state: “Here is my sequence”. This could be a consequence of the development of targeted therapies as presented by Chris Evans. He pointed out that molecular profile of a patient will have an increasing impact on the selection patients for a diagnostic procedure or even a specific therapy.
Login to read more...
|
EAU 2008 - Advances in Targeted Therapy and Tissue Engineering in Urology
Tuesday, 01 April 2008
MILAN, ITALY (UroToday.com) - Dr. Evans (Sacramento) presented a lecture on targeted therapies. Most drugs have a mechanistic “target”, such as the enzymes 5-α reductase in the treatment of BPH or 5-phosphodiesterase in the treatment of erectile dysfunction. However, in the current presentation, “targeted therapy” is defined as molecular targeting.
Login to read more...
|
EAU 2008 - The Use of Biological Markers in Clinical Practice
Tuesday, 01 April 2008
MILAN, ITALY (UroToday.com) - Dr. Bjartell (Lund) presented on the use of biological markers as they can apply to clinical practice. A useful biomarker, he said is a molecular test that provides additional information to clinical information.
Login to read more...
|
EAU 2008 - Management of the Retroperitoneum after Chemotherapy in Testicular Cancer: The Role and Extent of Surgery
Monday, 31 March 2008
MILAN, ITALY (UroToday.com) - Professor Droz (Lyon) moderated a debate on the retroperitoneum (RP) in testes cancer. Professor Albers (Kassel) presented the argument that post-chemotherapy RPLND is indicated in almost all patients.
Login to read more...
|
EAU 2008 - Molecular Detection of Lymph Node Involvement in Genitourinary Cancer
Tuesday, 01 April 2008
MILAN, ITALY (UroToday.com) - Dr. Michael Jewett (Toronto) presented the SIU lecture on detection and mapping regional lymph nodes (LN) in genitourinary cancer. He addressed the importance of LN in staging and therapy of GU cancers.
Login to read more...
|
Conference Coverage 
